medline.ch Onkologie
Leaderboard

En | De
Sie sind hier: Onkologie 10. August 2022
Suchen
medline.ch
Onkologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 79150  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 1582996  
   
Hepatocellular Carcinoma Incidence in Alcohol-associated Cirrhosis: Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
Huang DQ, Tan DJH, Ng CH, Amangurbanova M, Sutter N, Lin Tay PW, Lim WH, Yong JN, Tang A, Syn N, Muthiah MD, Tan EXX, Dave S, Tay B, Majzoub AM, Gerberi D, Kim BK, Loomba R.
PMID: 35940513 [PubMed - as supplied by publisher]


Effect of exercise on tumor markers - is exercise anti-tumorigenic in humans?: A scoping review of preliminary clinical investigations.
Crit Rev Oncol Hematol
Kang DW, Barnes O, Vander Heiden MG, Dieli-Conwright CM.
PMID: 35940512 [PubMed - as supplied by publisher]


Identification of a novel interplaying loop of PPARγ and respective lncRNAs are involved in colorectal cancer progress.
Int J Biol Macromol
Hajipour M, Mokhtari K, Mahdevar M, Esmaeili M, Peymani M, Nasr-Esfahani MH, Mirzaei S, Hasehmi M, Hushmandi K, Ghaedi K.
PMID: 35940433 [PubMed - as supplied by publisher]


Deregulated transcription factors and poor clinical outcomes in cancer patients.
Semin Cancer Biol
Li Y, Azmi AS, Mohammad RM.
PMID: 35940398 [PubMed - as supplied by publisher]


Annexin A5 as a targeting agent for cancer treatment.
Cancer Lett
Woodward A, Faria GN, Harrison RG.
PMID: 35940392 [PubMed - as supplied by publisher]


Classifying tumor brain images using parallel deep learning algorithms.
Comput Biol Med
Kazemi A, Shiri ME, Sheikhahmadi A, Khodamoradi M.
PMID: 35940159 [PubMed - as supplied by publisher]


Vitamin D and colorectal cancer - A practical review of the literature.
Cancer Treat Res Commun
Peixoto RD, Oliveira LJC, Passarini TM, Andrade AC, Diniz PH, Prolla G, Amorim LC, Gil M, Lino F, Garicochea B, Jácome A, Ng K.
PMID: 35940119 [PubMed - as supplied by publisher]


Microfluidic amperometric immunosensor based on porous nanomaterial towards claudin7 determination for colorectal cancer diagnosis.
Talanta
Ortega FG, Gomez GE, Boni C, García IC, Navas CG, D'vries RF, Molina Vallejos MP, Serrano MJ, Messina GA, Hernández JE, Fernández-Baldo MA.
PMID: 35940115 [PubMed - as supplied by publisher]


Exposure to artificial light at night: A common link for obesity and cancer?
Eur J Cancer
Muscogiuri G, Poggiogalle E, Barrea L, Tarsitano MG, Garifalos F, Liccardi A, Pugliese G, Savastano S, Colao A, Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group..
PMID: 35940056 [PubMed - as supplied by publisher]


First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements.
Eur J Cancer
Ma Y, Zhao H, Xue J, Liu L, Yang N, Zhang Y, Yang H, Hong S, Xiong Y, Zhang Z, Zeng L, Pan H, Zhou C, Zhang Y, Wang X, Han X, Wan X, Shao Y, Liu J, Yang Y, Huang Y, Zhao Y, Fang W, Li S, Zhang L.
PMID: 35940055 [PubMed - as supplied by publisher]


First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
Eur J Cancer
Stahler A, Modest DP, Fischer von Weikersthal L, Kaiser F, Decker T, Held S, Graeven U, Schwaner I, Denzlinger C, Schenk M, Kurreck A, Heinrich K, Gießen-Jung C, Neumann J, Kirchner T, Jung A, Stintzing S, Heinemann V.
PMID: 35940054 [PubMed - as supplied by publisher]


The role of hepatic and pancreatic metastatectomy in the management of metastatic renal cell carcinoma: A systematic review.
Surg Oncol
Rodger FE, Brennan PT, Nair R, Holroyd DJ.
PMID: 35940030 [PubMed - as supplied by publisher]


Indocyanine green fluorescence-guided surgery in head and neck cancer: A systematic review.
Am J Otolaryngol
De Ravin E, Venkatesh S, Harmsen S, Delikatny EJ, Husson MA, Lee JYK, Newman JG, Rajasekaran K.
PMID: 35939987 [PubMed - as supplied by publisher]


Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis.
Cancer Treat Rev
Fallara G, Robesti D, Nocera L, Raggi D, Marandino L, Belladelli F, Montorsi F, Malavaud B, Ploussard G, Necchi A, Martini A.
PMID: 35939976 [PubMed - as supplied by publisher]


Initial screening of gastric cancer using oral contrast-enhanced trans-abdominal ultrasonography in rural asymptomatic individuals.
Cancer Epidemiol
Shen L, Zhang D, Huang Y, Liu L, Zheng Y, Zhang L, Lu D, Cai J, Zhu R, Sun H, Shi M, Ni Y, Zhang J.
PMID: 35939867 [PubMed - as supplied by publisher]


Advancing Equity in Cancer Clinical Trials: Lessons From the Evidence.
JCO Oncol Pract
Guerra CE, Viswanath C.
PMID: 35939777 [PubMed - as supplied by publisher]


Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B.
JCO Precis Oncol
Bedard PL, Li S, Wisinski KB, Yang ES, Limaye SA, Mitchell EP, Zwiebel JA, Moscow JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.
PMID: 35939768 [PubMed - as supplied by publisher]


Disparity of Equitable Representation in Cancer Clinical Trials: Nursing Perspectives.
Clin J Oncol Nurs
Shapiro M.
PMID: 35939726 [PubMed - as supplied by publisher]


Effective Tumor Debulking With Ibrutinib Before Initiation of Venetoclax: Results From the CAPTIVATE Minimal Residual Disease (MRD) and Fixed-Duration (FD) Cohorts.
Clin Cancer Res
Barr PM, Tedeschi A, Wierda WG, Allan JN, Ghia P, Vallisa D, Jacobs R, O'Brien S, Grigg AP, Walker P, Zhou C, Ninomoto J, Krigsfeld G, Tam CS.
PMID: 35939599 [PubMed - as supplied by publisher]


The serum levels of IgM-free apoptosis inhibitor of macrophage /CD5L as a predictive and early diagnostic marker for NASH-associated hepatocellular carcinoma.
Hepatol Res
Okanoue T, Yamaguchi K, Shima T, Mitsumoto Y, Mizuno M, Katayama T, Seko Y, Moriguchi M, Umemura A, Itoh Y, Miyazaki T.
PMID: 35939571 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 1582996    Seite 1 von 79150  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1